Discovery on neural wiring could unlock paths toward treatment of spinal cord injury, stroke
On Sept. 16, 2026, a new discovery by neuroscientists at Brown University’s Carney Institute for Brain Science challenges…
-
-
Google DeepMind Launches AlphaGenome Atlas: A predictive map of every possible DNA letter change in the human genome
On Sept. 8, 2026, Google DeepMind released the AlphaGenome Atlas: a platform containing predictions for the effects of…
-
Researchers Discover Dozens of Genes Tied to OCD and Tic Disorders
On Aug. 31, 2026, a Rutgers-led international collaboration has identified 36 genes that substantially raise the risk for…
-
High-speed microscopy reveals electrical activity across the brain
On Aug. 14, 2026, a team of engineers at Massachusetts Institute of Technology (MIT) announced they have invented…
-
Jazz Pharmaceuticals to Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio, Valued at $1.32 Billion
On Aug. 10, 2026, Jazz Pharmaceuticals and Actio Biosciences announced the companies have entered into a definitive agreement…
-
China releases powerful DNA-screening AI tool for free to help fight rare diseases
On Aug. 10, 2026, Chinese researchers have created an open-source AI system capable of bridging the gap between…
-
UCLA scientists build ‘cell villages’ to map the genetics of brain cell fitness
On Aug. 3, 2026, UCLA researchers announced they have grown brain cells from dozens of genetically distinct donors…
-
Family History Increases Cancer Risk in BRCA-Tested Patients
On Jul. 30, 2026, a study led by Cedars-Sinai Health Sciences University investigators found that women who test…
-
Blood Proteins May Predict When Genetically At-Risk People Develop ALS
On Jul. 27, 2026, an international research team led by University of Miami Miller School of Medicine scientists…
-
Open-Access Genetic Map Provides Reference for What Almost Every Stem Cell Gene Does
On Jul. 13, 2026, a team led by bioengineers at the University of California San Diego has developed…
-
Researchers discover new form of hereditary prostate cancer
On July 9, 2026, researchers at the University of British Columbia announced they have identified a new form of hereditary…
-
Professor Chih-Ying Su Leaves U.S. to join Shenzhen Medical Academy of Research and Translation
On Jul. 1, 2026, Professor Chih-Ying Su, previously Professor and Vice Chair of the Department of Neurobiology at…
-
First-in-the-world gene therapy delivers missing gene directly to infant’s brain, marking historic milestone in precision medicine
On Jun. 8, 2026, an eight-month-old infant with a severe genetic epilepsy has become the first patient in…
-
Scientists Map Proteins From Billion-Year-Old Organism and Discover New Links to Rare Diseases
On May 27, 2026, a University of Texas at Austin-led team has identified genes by comparing groups of…
-
Engage Bio Acquired by Lilly for $202 million in cash to Accelerate Development of Non-Viral Genetic Medicines
On May 20, 2026, Engage Biologics, a preclinical biotechnology company pioneering non-viral DNA delivery, today announced that it…
-
Biotechnology | Cloning | CRISPR | Environmental | Genomics
Artificial Womb Construction Nearing Completion
On May 19, 2026, Colossal Biosciences announced it is developing a functional artificial womb capable of growing a…
-
Biotechnology | Cloning | CRISPR | Environmental | Genomics
Colossal Biosciences Artificial Egg Hatches 26 Chickens in Breakthrough Step Toward Dodo and Moa De-Extinction
On May 19, 2026, Colossal Biosciences announced their artificial egg — a silicone-membrane synthetic shell system — successfully…
-
Biotechnology | Cloning | CRISPR | Genomics | Veterinary
Colossal Biosciences Is Working to Bring Back the Bluebuck, an Antelope Hunted to Extinction in 1800
On Apr. 30, 2026, Colossal Biosciences, the world’s de-extinction company, announced that it is working to de-extinct the…
-
Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera for $2.3 billion in cash
On Apr. 27, 2026, Eli Lilly and Ajax Therapeutics announced a definitive agreement for Lilly to acquire Ajax….
-
Biotechnology | Disease | FDA | Therapeutics
FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss
On Apr. 23, 2026, the U.S. Food and Drug Administration (FDA) approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual…
-
Autoimmune diseases share genetic patterns
On Apr. 9, 2026, researchers from Karolinska Institutet and collaborating institutions report that different autoimmune diseases often share…
-
UCLA researchers develop low-cost blood test to detect multiple cancers and other diseases from a single sample
On Apr. 6, 2026, scientists from the University of California, Los Angeles (UCLA) announce they have developed a…
-
New Genetic Risk Score Better Predicts Diabetes, Obesity and Downstream Complications
On Mar. 16, 2026, investigators from Mass General Brigham announce they have built metabolic polygenic risk scores (PRS) for predicting…
-
Blood Test Predicts Dementia in Women as Many as 25 Years Before Symptoms Begin
On Mar. 10, 2026, researchers from the University of California San Diego have found that a novel blood-based…
-
Google DeepMind launches AI tool to help identify genetic drivers of disease
On Jan. 28, 2026, researchers at Google DeepMind have unveiled their latest artificial intelligence tool and claimed it…
-
New atlas could help researchers studying neurological disease
On Jan. 22, 2026, researchers backed by a Knight Initiative for Brain Resilience Catalyst Momentum Award have laid out…
-
Study reveals genetic factors influencing pregnancy loss
On Jan. 21, 2026, a Johns Hopkins University-led team demonstrated robust connections between specific variations in a mother’s…
-
Widely used pesticide linked to more than doubled Parkinson’s risk
On Jan. 7, 2026, a study from the University of California, Los Angeles (UCLA) Health found that long-term…
-
Biotechnology | Cardiology | Clinical Research | CRISPR | Disease | Non-Profit Research | Oncology | Rare Disease | Therapeutics
CIRM approves over $160M to support preclinical and clinical research, advances education opportunities and access to clinical trials
On Dec. 11, 2025, the California Institute for Regenerative Medicine (CIRM) governing board approved funding of over $160…
-
UCLA team discovers how to target ‘undruggable’ protein that fuels aggressive leukemia
On Dec. 9, 2025, researchers at the UCLA Health Jonsson Comprehensive Cancer Center announced they have identified a…
